The role of stearoyl-coenzyme A desaturase 1 in clear cell renal cell carcinoma

MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs <i>In vitro</i> and <i>In vivo</i>

Hiroshi Hirai, Hiroshi Sootome, Yoko Nakatsuru et al. · Molecular Cancer Therapeutics · 2010 · 938 citations · Full text

Medicine, Oncology, Pharmacology +17

Classification of renal cell carcinoma

Stephan St�rkel, John N. Eble, Kiran Adlakha et al. · Cancer · 1997 · 878 citations · Full text

Medicine, Oncology, Pathology +17

Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial–mesenchymal transition

Hanna Y. Irie, Rachel V. Pearline, Dorre A. Grueneberg et al. · The Journal of Cell Biology · 2005 · 590 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function

Lynsey M. Meikle, Kristen Pollizzi, Anna Egnor et al. · Journal of Neuroscience · 2008 · 503 citations · Full text

Medicine, Neuroscience, Pharmacology +14

The mTOR Inhibitor RAD001 Sensitizes Tumor Cells to DNA-Damaged Induced Apoptosis through Inhibition of p21 Translation

Iwan Beuvink, Anne Boulay, Stefano Fumagalli et al. · Cell · 2005 · 490 citations · Full text

Life Sciences, Oncology, Pharmacology +14